Improving the UK's attractiveness for industry research, development & manufacturing

Research & Development
Scientists

title-strip icon Clinical research

Clinical trials are an essential part of the research and development (R&D) of new medicines and vaccines, bringing benefits to patients, the NHS and the economy.

 View looking up at a scientist using a pipette

title-strip icon Manufacturing and quality

The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.

 Three analysts look at the charts on a screen

title-strip icon Regulatory science

This is the science of developing new tools, standards and approaches to evaluate the efficacy, safety, quality and performance of medical products in order to assess benefit-risk and facilitate a sound and transparent regulatory decision-making.

 Scientist looking at petri dish on the microscope platform

title-strip icon Pharmacovigilance - drug safety

Drug safety (also known as pharmacovigilance), is the science of detection, assessment, understanding and prevention of side effects which allows us to understand more about the risks and benefits of a medicine.

Injection

title-strip icon Genomics in healthcare and research

The ABPI is committed to supporting the sector in bringing the latest advances in genomics technologies and treatments to patients, and genomics research to develop new drugs to treat disease.

 Woman at a meeting, sits smiling at the unseen delegates

title-strip icon People-centred research

The ABPI's People-centred Research Hub features a collection of member case studies that promote industry best practices in diversity and inclusion, patient and public involvement, and research transparency.